Dr. Eugenia Chang
Claim this profileSaint Luke's Cancer Institute - Boise
Expert in Tumors
Expert in Brain Tumor
52 reported clinical trials
97 drugs studied
About Eugenia Chang
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Radiation Oncology at Saint Luke's Cancer Institute - Boise.
- Board certified in Radiation Oncology.
Experience:
- Currently serving as a Radiation Oncologist at Saint Luke's Cancer Institute - Boise.
Area of expertise
1Tumors
Global LeaderStage IV
NTRK1 positive
NTRK positive
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Saint Luke's Cancer Institute - Boise
Saint Luke's Mountain States Tumor Institute
Clinical Trials Eugenia Chang is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Eugenia Chang
Clinical Trial Related7 years of experience running clinical trials · Led 52 trials as a Principal Investigator · 21 Active Clinical TrialsTreatments Eugenia Chang has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Laboratory Biomarker Analysis
Breakdown of trials Eugenia Chang has run
Tumors
Brain Tumor
Neuroblastoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eugenia Chang specialize in?
Eugenia Chang focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are NTRK1 positive.
Is Eugenia Chang currently recruiting for clinical trials?
Yes, Eugenia Chang is currently recruiting for 16 clinical trials in Boise Idaho. If you're interested in participating, you should apply.
Are there any treatments that Eugenia Chang has studied deeply?
Yes, Eugenia Chang has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Eugenia Chang?
Apply for one of the trials that Eugenia Chang is conducting.
What is the office address of Eugenia Chang?
The office of Eugenia Chang is located at: Saint Luke's Cancer Institute - Boise, Boise, Idaho 83712 United States. This is the address for their practice at the Saint Luke's Cancer Institute - Boise.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.